Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 34,926 | 39,069 | 26,864 | 33,523 | 34,871 |
| Cost of Goods | 26,982 | 28,346 | 22,175 | 28,327 | 26,972 |
| Gross Profit | 7,944 | 10,723 | 4,689 | 5,196 | 7,899 |
| Operating Expenses | 9,022 | 7,865 | 8,382 | 8,453 | 7,776 |
| Operating Income | -96 | 3,204 | -3,518 | -2,930 | 1,095 |
| Interest Expense | 717 | 519 | 479 | 984 | 547 |
| Other Income | -334 | 10 | -248 | -9 | 77 |
| Pre-tax Income | -1,147 | 2,695 | -4,245 | -3,923 | 625 |
| Income Tax | -580 | 1,087 | -1,380 | 458 | -238 |
| Net Income Continuous | -567 | 1,608 | -2,865 | -4,381 | 863 |
| Net Income | $-567 | $1,608 | $-2,865 | $-4,381 | $863 |
| EPS Basic Total Ops | -0.10 | 0.29 | -0.52 | -0.81 | 0.16 |
| EPS Basic Continuous Ops | -0.10 | 0.29 | -0.52 | -0.80 | 0.16 |
| EPS Diluted Total Ops | -0.10 | 0.27 | -0.52 | -0.76 | 0.16 |
| EPS Diluted Continuous Ops | -0.10 | 0.27 | -0.52 | -0.72 | 0.14 |
| EBITDA(a) | $1,094 | $4,358 | $-2,377 | $-1,506 | $2,140 |